Literature DB >> 12850916

On the origins and relationships of Newcastle disease virus vaccine strains Hertfordshire and Mukteswar, and virulent strain Herts'33.

Alíz Czeglédi1, Enikö Wehmann, B Lomniczi.   

Abstract

The origins and relationships of Newcastle disease virus (NDV) vaccine strains Hertfordshire (H) and Mukteswar, and the virulent Herts'33 were studied using partial sequence analysis of the fusion protein gene. The mesogenic strain H was obtained by egg passages of a field virus isolated in England in 1933 (later known as Herts'33). Different lines of the strain Herts'33, however, divided into two distinct groups: genotype IV, and a hitherto undescribed lineage, which comprised the Weybridge line (Herts'33/56). Vaccine strain H and the two clusters comprising viruses designated Herts'33 displayed 6.5 to 6.8% and 15.6 to 16.3% mutational distances, respectively, which precluded parent-offspring relationships with either of them. In contrast, the different lines of the vaccine strain Mukteswar, which was reportedly derived from an Indian field isolate in the mid-1940s, showed 98.9 to 100% sequence similarity to strain H. It is therefore probable that the two vaccines were derived from the same virus stock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850916     DOI: 10.1080/0307945031000097868

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  13 in total

1.  Molecular characterization of virulent Newcastle disease virus isolates from chickens during the 1998 NDV outbreak in Kazakhstan.

Authors:  Andrey Bogoyavlenskiy; Vladimir Berezin; Alexey Prilipov; Eugeniy Usachev; Olga Lyapina; Svetlana Levandovskaya; Ilya Korotetskiy; Valentina Tolmacheva; Nailya Makhmudova; Svetlana Khudyakova; Gulnur Tustikbaeva; Irina Zaitseva; Elmira Omirtaeva; Olga Ermakova; Klara Daulbaeva; Saule Asanova; Aydyn Kydyrmanov; Marat Sayatov; Daniel King
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

2.  p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines.

Authors:  Zsolt Fábián; Christine M Csatary; József Szeberényi; Laszlo K Csatary
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Newcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV.

Authors:  Olivier F Maminiaina; Patricia Gil; François-Xavier Briand; Emmanuel Albina; Djénéba Keita; Harentsoaniaina Rasamoelina Andriamanivo; Véronique Chevalier; Renaud Lancelot; Dominique Martinez; R Rakotondravao; Jean-Joseph Rajaonarison; M Koko; Abel A Andriantsimahavandy; Véronique Jestin; Renata Servan de Almeida
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

4.  Real-time PCR-based pathotyping of Newcastle disease virus by use of TaqMan minor groove binder probes.

Authors:  T Farkas; E Székely; S Belák; I Kiss
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

5.  Newcastle disease outbreaks in Kazakhstan and Kyrgyzstan during 1998, 2000, 2001, 2003, 2004, and 2005 were caused by viruses of the genotypes VIIb and VIId.

Authors:  Andrey Bogoyavlenskiy; Vladimir Berezin; Alexey Prilipov; Eugeniy Usachev; Olga Lyapina; Ilya Korotetskiy; Irina Zaitceva; Saule Asanova; Aydyn Kydyrmanov; Klara Daulbaeva; Larisa Shakhvorostova; Marat Sayatov; Daniel King
Journal:  Virus Genes       Date:  2009-05-23       Impact factor: 2.332

6.  Genotypic and pathotypic characterization of Newcastle disease viruses from India.

Authors:  Krishnaswamy G Tirumurugaan; Sunil Kapgate; Manavalan K Vinupriya; Kumanan Vijayarani; Kathaperumal Kumanan; Subbiah Elankumaran
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

Review 7.  Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer.

Authors:  Volker Schirrmacher; Philippe Fournier
Journal:  Methods Mol Biol       Date:  2009

8.  Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov.

Authors:  Sivam Visnuvinayagam; K Thangavel; N Lalitha; S Malmarugan; Kuppannan Sukumar
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

9.  Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host.

Authors:  Philippe Fournier; Volker Schirrmacher
Journal:  Biology (Basel)       Date:  2013-07-02

10.  Genotype characterization of commonly used Newcastle disease virus vaccine strains of India.

Authors:  Sohini Dey; Madhan Mohan Chellappa; Satish Gaikwad; Jag Mohan Kataria; Vikram N Vakharia
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.